Immunopathogenesis of multiple sclerosis: the role of T cells.

Multiple sclerosis is considered to be an autoimmune disease that results from aberrant immune responses to central nervous system antigens. T cells are considered to be crucial in orchestrating an immunopathological cascade that culminates in damage to the myelin sheath, oligodendrocytes and axons.

[1]  J. Burns,et al.  Isolation of myelin basic protein–specific T cells predominantly from the memory T‐cell compartment in multiple sclerosis , 1999, Annals of neurology.

[2]  T. Johns,et al.  The Structure and Function of Myelin Oligodendrocyte Glycoprotein , 1999, Journal of neurochemistry.

[3]  M. Kronenberg,et al.  CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.

[4]  J. V. Noort,et al.  Epstein-Barr virus induced expression and HLA-DR restricted presentation of αB-crystallin, a major human myelin antigen , 1998, Journal of Neuroimmunology.

[5]  T. Olsson,et al.  Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis , 1998, Journal of Neuroimmunology.

[6]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[7]  M. Kaufman.  Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides is limited? , 1998, Journal of theoretical biology.

[8]  F. Zipp,et al.  Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. , 1998, Brain : a journal of neurology.

[9]  V. Rivera,et al.  Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. , 1998, International immunology.

[10]  Jingwu Z. Zhang,et al.  γδ T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination , 1998, Journal of Neuroimmunology.

[11]  Jingwu Z. Zhang,et al.  T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications , 1998, European journal of immunology.

[12]  M. J. Walsh,et al.  Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. , 1998, The Journal of clinical investigation.

[13]  H. McFarland,et al.  T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects , 1998, Journal of Neuroimmunology.

[14]  R. Houghten,et al.  Probing degeneracy in T-cell recognition using peptide combinatorial libraries. , 1998, Immunology today.

[15]  J. Antel,et al.  MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. , 1998, Journal of immunology.

[16]  A. Consiglio,et al.  Proinflammatory cytokines regulate antigen‐independent T‐cell Activation by two separate calcium‐signaling pathways in multiple sclerosis patients , 1998, Annals of neurology.

[17]  C. June,et al.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. , 1998 .

[18]  D. E. Anderson,et al.  Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. , 1998, Journal of immunology.

[19]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[20]  Giunti,et al.  A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients , 1998, Clinical and experimental immunology.

[21]  M. Freedman,et al.  Mechanism of γδ T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis , 1997, Journal of Neuroimmunology.

[22]  D. Taub,et al.  CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10. , 1998, Journal of immunology.

[23]  L. Weiner,et al.  Human CD8+ TCR-α β + and TCR-γ δ + cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms , 1997, Journal of Neuroimmunology.

[24]  A. Ben-nun,et al.  Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.

[25]  C. Brosnan,et al.  Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. , 1997, Journal of immunology.

[26]  B. Hemmer,et al.  Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype , 1997, Neurology.

[27]  H. Lassmann,et al.  Expression of αB-crystallin in glia cells during lesional development in multiple sclerosis , 1997, Journal of Neuroimmunology.

[28]  Eric O Long,et al.  T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells , 1997, Journal of Neuroimmunology.

[29]  M. Pender,et al.  Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. , 1997, Brain : a journal of neurology.

[30]  F. Zipp,et al.  Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. , 1997, Brain : a journal of neurology.

[31]  D E Banks,et al.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. , 1997, The Journal of clinical investigation.

[32]  Jingwu Z. Zhang,et al.  Cytokine profile of myelin basic protein—reactive T cells in multiple sclerosis and healthy individuals , 1997, Annals of neurology.

[33]  H. Warnatz,et al.  Clonal expansion and decreased occurrence of peripheral blood gamma delta T cells of the V delta 2J delta 3 lineage in multiple sclerosis patients. , 1997, International immunology.

[34]  W. Tourtellotte,et al.  Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. , 1997, Journal of neuropathology and experimental neurology.

[35]  E. Sercarz,et al.  Regulatory T Cells Specific for the Same Framework 3 Region of the Vβ8.2 Chain Are Involved in the Control of Collagen II–induced Arthritis and Experimental Autoimmune Encephalomyelitis , 1997, The Journal of experimental medicine.

[36]  Bernhard Hemmer,et al.  Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.

[37]  D. Hafler,et al.  Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease , 1997, The Journal of experimental medicine.

[38]  Roland Martin,et al.  2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases , 1997, Journal of Neuroimmunology.

[39]  R. Karr,et al.  HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides , 1997, Journal of Neuroimmunology.

[40]  J. Coligan,et al.  Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. , 1997, Journal of immunology.

[41]  R. Zinkernagel,et al.  Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.

[42]  R. Kinkel,et al.  Diversity and plasticity of self recognition during the development of multiple sclerosis. , 1997, The Journal of clinical investigation.

[43]  B. Hemmer,et al.  Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. , 1997, Journal of immunology.

[44]  A. Perl,et al.  Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. , 1997, The Journal of clinical investigation.

[45]  T. Johns,et al.  Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis , 1997, Journal of Molecular Medicine.

[46]  L. Weiner,et al.  Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12 , 1997, Journal of Neuroimmunology.

[47]  H. Weiner,et al.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[49]  O. Mandelboim,et al.  Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.

[50]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[51]  U. Utz,et al.  Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99) , 1996, European journal of immunology.

[52]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[53]  P. Calabresi,et al.  Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83–99) , 1996, Journal of neuroscience research.

[54]  Y. Xia,et al.  Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. , 1996, Journal of immunology.

[55]  H. McFarland,et al.  A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. , 1996, Journal of immunology.

[56]  C. Brosnan,et al.  A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. , 1996, Journal of immunology.

[57]  C. Brosnan,et al.  CDlb is expressed in multiple sclerosis lesions , 1996, Journal of Neuroimmunology.

[58]  J. Sprent,et al.  Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.

[59]  L. Kotilinek,et al.  Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2′,3′ cyclic nucleotide 3′ phosphodiesterase that is cross‐reactive with a heat shock protein alters the course of EAE , 1996, Journal of neuroscience research.

[60]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[61]  C. Brosnan,et al.  Heat Shock Proteins and Multiple Sclerosis: A Review , 1996, Journal of neuropathology and experimental neurology.

[62]  C. Pozzilli,et al.  The immune response to Mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis , 1996, Journal of Neuroimmunology.

[63]  D. Hafler,et al.  TCR usage in human and experimental demyelinating disease. , 1996, Immunology today.

[64]  L. Steinman.  A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Antel,et al.  Myelin basic protein and human coronavirus 229E cross‐reactive T cells in multiple sclerosis , 1996, Annals of neurology.

[66]  W. Paul,et al.  Role of NK1.1+ T Cells in a TH2 Response and in Immunoglobulin E Production , 1995, Science.

[67]  A. Bendelac,et al.  Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[69]  T. Tabira,et al.  Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant. , 1995, International immunology.

[70]  H. Ohno,et al.  Developmental arrest of NK1.1+ T cell antigen receptor (TCR)- alpha/beta+ T cells and expansion of NK1.1+ TCR-gamma/delta+ T cell development in CD3 zeta-deficient mice , 1995, Journal of Experimental Medicine.

[71]  H. Macdonald.  NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function , 1995, The Journal of experimental medicine.

[72]  C. Polman,et al.  The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.

[73]  J. Satoh,et al.  Constitutive and inducible expression of heat shock protein HSP72 in oligodendrocytes in culture , 1995, Neuroreport.

[74]  D. Hafler,et al.  Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. , 1995, Journal of immunology.

[75]  A. Waisman,et al.  Major T-cell responses in multiple sclerosis. , 1995, Molecular medicine today.

[76]  L. Weiner,et al.  Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. , 1995, Journal of immunology.

[77]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[78]  L. Battistini,et al.  Multiple Sclerosis: Limited Diversity of the Vδ2‐Jδ3 T‐Cell Receptor in Chronic Active Lesions , 1995 .

[79]  H. McFarland,et al.  Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.

[80]  D. Mattson,et al.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis , 1994, The Journal of experimental medicine.

[81]  A. Sette,et al.  T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans , 1994, Journal of Neuroimmunology.

[82]  K. Parker,et al.  Autoreactive CD8+ cell responses to human myelin protein-derived peptides , 1994, Journal of Neuroimmunology.

[83]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[84]  P. Pileri,et al.  Antigen-independent activation of naive and memory resting T cells by a cytokine combination , 1994, The Journal of experimental medicine.

[85]  H. Rammensee,et al.  Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.

[86]  L. Steinman,et al.  Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. , 1994, The Journal of clinical investigation.

[87]  D. Hafler,et al.  Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. , 1994, Journal of immunology.

[88]  W. Paul,et al.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 , 1994, The Journal of experimental medicine.

[89]  H. Weiner,et al.  Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis , 1994, The Journal of experimental medicine.

[90]  M. Freedman,et al.  Cytokine induction of heat shock protein expression in human oligodendrocytes: An interleukin-1-mediated mechanism , 1994, Journal of Neuroimmunology.

[91]  C Oseroff,et al.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones , 1994, The Journal of experimental medicine.

[92]  Norbert,et al.  Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. , 1993, The Journal of clinical investigation.

[93]  R. Milo,et al.  Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. , 1993, The Journal of clinical investigation.

[94]  Roland Martin,et al.  Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis , 1993, Annals of neurology.

[95]  S. Hauser,et al.  The T‐cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T‐cell receptor usage , 1993, Annals of neurology.

[96]  E. Sercarz,et al.  The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease , 1993, The Journal of experimental medicine.

[97]  H. McFarland,et al.  Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients , 1993, Journal of Neuroimmunology.

[98]  S. Balk,et al.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.

[99]  G. Gros,et al.  Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. , 1993, Science.

[100]  C. Pozzilli,et al.  Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis , 1993, European journal of immunology.

[101]  A. Begovich,et al.  Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.

[102]  A. Steck,et al.  The T‐lymphocyte response against myelin‐associated glycoprotein and myelin basic protein in patients with multiple sclerosis , 1993, Neurology.

[103]  L. Kappos,et al.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. , 1993, The Journal of clinical investigation.

[104]  C. Janeway,et al.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.

[105]  H. McFarland,et al.  T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. , 1993, Autoimmunity.

[106]  C. Pozzilli,et al.  T-lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kDa heat shock proteins in multiple sclerosis. , 1992, Journal of autoimmunity.

[107]  H. Offner,et al.  Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain. , 1992, Journal of immunology.

[108]  D. Hafler,et al.  Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[109]  T. Olsson,et al.  Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[110]  T. Olsson,et al.  Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis , 1992, European journal of immunology.

[111]  E. D. Robinson,et al.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.

[112]  M. Freedman,et al.  Peripheral blood γ‐δ T cells lyse fresh human brain—Derived oligodendrocytes , 1991 .

[113]  G. Nedwin,et al.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[114]  S. Romagnani.  Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.

[115]  C. Brosnan,et al.  Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[116]  W. Hickey,et al.  Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides , 1991, Journal of Neuroimmunology.

[117]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[118]  D. Gold,et al.  Protection against experimental encephalomyelitis: Idiotypic autoregulation induced by a non-encephalitogenic T cell clone expressing a cross-reactive T cell receptor V gene , 1991, Journal of Neuroimmunology.

[119]  T. Olsson,et al.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls , 1991, European journal of immunology.

[120]  A. Ben-nun,et al.  Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[121]  T. Olsson,et al.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.

[122]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[123]  Eric O Long,et al.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.

[124]  Eric O Long,et al.  HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. , 1990, Journal of immunology.

[125]  L. Kappos,et al.  Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.

[126]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[127]  K. Haskins,et al.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.

[128]  H. Nakajima,et al.  The effect of treatment with interferon‐gamma on type II collagen‐induced arthritis , 1990, Clinical and experimental immunology.

[129]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[130]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[131]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[132]  J. Seidman,et al.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. , 1990, Science.

[133]  R J Albertini,et al.  T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.

[134]  R. Young,et al.  Stress proteins and immunology. , 1990, Annual review of immunology.

[135]  H. Kirchner,et al.  Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.

[136]  J. Richert,et al.  Peptide specificities of myelin basic protein‐reactive human T‐cell clones , 1988, Neurology.

[137]  R. Hirsch,et al.  Treatment of multiple sclerosis with gamma interferon , 1987, Neurology.

[138]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[139]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[140]  B. Zweiman,et al.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.